How Do We Embrace AI Without Compromising Ethics, Governance, and Trust?

How Do We Embrace AI Without Compromising Ethics, Governance, and Trust?

That was the central question explored during Medicines Australia’s recent webinar, Conversations & The Code: Compliance and Decision Making – Navigating AI and Emerging Technologies.

Bringing together Sophie Seck, Senior Manager, Ethics & Compliance at Medicines Australia, Mark Baxter, VP of Innovation at RxPx, and Andrew Weekes, Independent Consultant at InspiRx, the discussion focused on a practical challenge facing every pharmaceutical organisation: how to harness AI’s potential while maintaining the governance, transparency, and accountability that underpin patient trust.

Here are three key takeaways from the discussion.